| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $90.8M | +3.0% |
| SG&A Expense | $28.2M | -7.0% |
| Operating Income | -$121.2M | -2.2% |
| Income Tax | $0 | — |
| Net Income | -$112.6M | +3.1% |
| EPS (Basic) | -$2.42 | +8.3% |
| EPS (Diluted) | -$2.42 | +8.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $57.0M | +94.8% |
| Short-term Investments | $97.0M | -43.7% |
| Current Assets | $158.2M | -31.5% |
| Total Assets | $173.6M | -37.7% |
| Current Liabilities | $12.0M | -30.1% |
| Total Liabilities | $14.3M | -29.9% |
| Stockholders' Equity | $159.3M | -28.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$100.0M | -12.4% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $109.9M | +1708.6% |
| Financing Cash Flow | -$7.8M | -773.1% |
| Free Cash Flow | -$100.0M | -9.0% |